Petina Musara

Biographic Data

ID	4781535
NAME	Petina Musara
GIVEN NAMES	Petina
FAMILY NAME	Musara
SIGNATURE	MUSARA P
AFFILIATIONS	University of Zimbabwe
ORCID	0000-0001-9668-4344
VERIFIED	Yes
TOTAL WORKS	21
TOTAL CITATIONS	1
WORKS AS AUTHOR	21
WORKS AS EDITOR	0
FIRST PUBLICATION YEAR	2011
LATEST PUBLICATION YEAR	2025
H-INDEX	1

“…This could be a noble idea and a game changer.” The potential of a dual prevention pill for HIV and pregnancy prevention among adolescent girls and young women in Zimbabwe
Open AccessAdlight Dandadzi, S Mathur et al.ARTICLEPLOS Global Public Health2025
Adolescent girls and young women (AGYW) in Zimbabwe bear a double burden of HIV and unmet need despite the progress made in provision of family planning and oral pre-exposure prophylaxis (PrEP). We elicited opinions from AGYW and health care providers (HCPs) about a dual prevention pill (DPP) in development that combines oral contraceptives (OCs) with oral PrEP to simultaneously prevent unintended pregnancy and HIV, and potentially increase uptak…
Motivations for Starting and Stopping PrEP
Open AccessLisa Mills, Nomhle Khoza et al.ARTICLEAIDS and Behavior2025
Oral PrEP effectiveness depends on consistent use during periods of potential HIV exposure, but adolescent girls and young women (AGYW) find this challenging. Data on PrEP use decision-making and alignment with risk among AGYW are limited. From 2016 to 2018, we conducted in-depth interviews with participants in HPTN 082, an open-label PrEP study in South Africa and Zimbabwe, to explore reasons for PrEP starts, stops, and restarts. Of 60 PrEP acce…
A Dual Prevention Pill for HIV & Pregnancy Prevention
Open AccessNyaradzo M Mgodi, J Brady Burnett-Zieman et al.ARTICLEAIDS and Behavior2025
Adolescent girls and young women (AGYW) in sub-Saharan Africa are at risk for HIV/unintended pregnancy. Adherence and continuation to effective oral pre-exposure prophylaxis (PrEP) are limited in AGYW. We hypothesized that an over-encapsulated dual prevention pill (DPP) combining PrEP + oral contraceptive (OC) would be preferred, acceptable, and improve adherence compared to PrEP alone. We randomized HIV-uninfected, 16-24 year-olds 1:1 to use DPP…
“We chose PrEP because I wanted to be sure that this child my wife was going to conceive was indeed mine.” Factors influencing the choice of safer conception methods and experiences with its use
Open AccessJoelle Brown, Joelle M Brown et al.ARTICLEBMC Public Health2024
The differences in method preferences and experiences voiced by participants in this study and in other studies from the region point to the importance of having a variety of safer conception options in the service delivery package and addressing concerns about paternity, intimacy, and method-related attributes to enable HIV sero-discordant couples to safely achieve their reproductive goals
Perception of couples’ on multipurpose prevention technology attribute choice
Open AccessAdlight Dandadzi, Alinda M Young et al.ARTICLEBMC Public Health2024
Addressing the myths and misconceptions surrounding the use of contraceptives is crucial in promoting their acceptance and ultimate use. Strategies for addressing the drawbacks women might experience while using a particular product should be in place as new MPTs progress through the development pipeline and approach roll-out
Preventing HIV and achieving pregnancy among HIV sero-different couples
Open AccessJoelle Brown, Serah Gitome et al.ARTICLEPLOS Global Public Health2023
Safer conception services are needed to minimize HIV transmission among HIV sero-different couples desiring pregnancy. Few studies have evaluated the choices couples make when offered multiple safer conception methods or real-world method acceptability and effectiveness. We piloted a comprehensive safer conception program ( Clintrials . gov identifier: NCT03049176) for HIV sero-different couples planning pregnancy in Zimbabwe to measure feasibili…
Understanding the role of men in women's use of the vaginal ring and oral PrEP during pregnancy and breastfeeding
Petina Musara, Miriam Hartmann et al.ARTICLEAfrican Journal of AIDS Research2022
We examined men's influence on women's interest in biomedical HIV prevention during pregnancy and breastfeeding through structured questionnaires and focus group discussions with currently or recently pregnant and breastfeeding (P/BF) women ( n = 65), men with P/BF partners ( n = 63) and mothers/mothers-in-law of P/BF women ( n = 68) in eastern and southern Africa. Data were transcribed, coded and summarised into analytical memos. Men were depict…
Couples’ Preferences for “2 in 1” Multipurpose Prevention Technologies to Prevent Both HIV and Pregnancy
Open AccessAlexandra M Minnis, Juliane Etima et al.ARTICLEAIDS and Behavior2022
Couples’ decision making regarding the use of multipurpose prevention technology (MPT) for pregnancy and HIV prevention
Open AccessMarie C D Stoner, Erica N Browne et al.ARTICLEAIDS and Behavior2022
Religious leaders’ role in pregnant and breastfeeding women’s decision making and willingness to use biomedical HIV prevention strategies
Alinda M Young, Julia Ryan et al.ARTICLECulture Health & Sexuality2022
Oral Pre-Exposure Prophylaxis (PrEP) is an established option, and the dapivirine vaginal ring is emerging as a promising strategy for HIV prevention option for women. Because of this, understanding the contextual and cultural factors that will support the increased uptake of these products is crucial. In sub-Saharan Africa, religious leaders may be important stakeholders to involve in product information, education and roll-out. We conducted a s…
Impact and experience of participant engagement activities in supporting dapivirine ring use among participants enrolled in the phase III MTN-020/Aspire study
Open AccessMorgan Garcia, Ellen Luecke et al.ARTICLEBMC Public Health2021
Our analysis supports the growing body of work illustrating the importance of meaningfully engaging research participants to achieve study success and aligns with other analyses of adherence support efforts during ASPIRE. While causation between PEA attendance and product use cannot be established, residual drug levels in returned rings strongly correlated with participant attendance at PEAs, and the benefits of incorporating PEAs should be consi…
Sexual Attitudes, Beliefs, Practices, and HIV Risk During Pregnancy and Post-delivery
Open AccessJulia Ryan, Alinda M Young et al.ARTICLEAIDS and Behavior2021
Women who acquire HIV during the pregnancy and breastfeeding periods have a higher risk of transmitting the virus to their child than women who become infected with HIV before pregnancy. We explore the context of sexual beliefs and practices that may shape both HIV risk and willingness to use HIV prevention products during pregnancy and postpartum in Malawi, South Africa, Uganda and Zimbabwe. Twenty-three single sex focus group discussions and 36…
Preferences and Acceptability of Vaginal Delivery Forms for HIV Prevention Among Women, Male Partners and Key Informants in South Africa and Zimbabwe
Open AccessPetina Musara, Cecilia Milford et al.ARTICLEAIDS and Behavior2020
Application of a Body Map Tool to Enhance Discussion of Sexual Behavior in Women in South Africa, Uganda, and Zimbabwe
Open AccessSarita Naidoo, Zoe Duby et al.ARTICLECAM2020Cited by: 1References: 12
Body mapping methods are used in sexual and reproductive health studies to encourage candid discussion of sex and sexuality, pleasure and pain, sickness and health, and to understand individuals’ perceptions of their bodies. VOICE-D, a qualitative follow-up study to the VOICE trial, developed and used a body map tool in the context of individual in-depth interviews with women in South Africa, Uganda, and Zimbabwe. The tool showed the outline of a…
Perspectives from Young South African and Zimbabwean Women on Attributes of Four (Placebo) Vaginal Microbicide Delivery Forms
Open Accesson behalf of the Quatro Study Team, Rachel Weinrib et al.ARTICLEAIDS and Behavior2019
How well a product fit in with participants' lifestyles was important to their overall satisfaction. For on-demand products, greater flexibility around timing of use was desired, to avoid coital dependency of the dosing
Negative rumours about a vaginal ring for HIV-1 prevention in sub-Saharan Africa
Miria Chitukuta, Zoe Duby et al.ARTICLECulture Health & Sexuality2019
Rumours may influence health-related behaviours, including the uptake of and adherence to HIV prevention products. This study assessed the safety and effectiveness of a vaginal ring delivering the antiretroviral dapivirine for HIV prevention in Africa. We explored negative rumours about study participation and the vaginal ring amongst study participants and their communities in Malawi, Uganda, South Africa and Zimbabwe. In total 214 women partici…
How Presentation of Drug Detection Results Changed Reports of Product Adherence in South Africa, Uganda and Zimbabwe
Open AccessPetina Musara, Elizabeth Montgomery et al.ARTICLEAIDS and Behavior2017
Misreporting of Product Adherence in the MTN-003/Voice Trial for HIV Prevention in Africa
Open AccessElizabeth Montgomery, Barbara S Mensch et al.ARTICLEAIDS and Behavior2016
Effects of Partnership Change on Microbicide Gel Adherence in a Clinical Trial (HPTN 035)
Open AccessPamina M Gorbach, Clifton W Kelly et al.ARTICLEAIDS and Behavior2013
Preference Between Precoital and Daily Use of Duet® and BufferGel in Zimbabwe
Open AccessAriane Van Der Straten, Elizabeth Montgomery et al.ARTICLEAIDS and Behavior2012
Preventive Misconception as a Motivation for Participation and Adherence in Microbicide Trials
Open AccessCynthia Woodsong, Patty Alleman et al.ARTICLEAIDS and Behavior2011